Northwestern Mutual Wealth Management
AKBA icon

Northwestern Mutual Wealth Management’s Akebia Therapeutics AKBA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-149
Closed -$207 – 4090
2026
Q1 		$207 Buy
+149
New +$205 ﹤0.01% 3938
2025
Q4 		– Sell
-748
Closed -$2.04K – 4011
2025
Q3 		$2.04K Buy
+748
New +$2.49K ﹤0.01% 3383
2025
Q2 		– Sell
-5
Closed -$10 – 3662
2025
Q1 		$10 Buy
+5
New +$10 ﹤0.01% 3622
2023
Q1 		– Sell
-374
Closed -$216 – 3352
2022
Q4 		$216 Buy
+374
New +$117 ﹤0.01% 3179

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northwestern Mutual Wealth Management's AKBA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Akebia Therapeutics (AKBA) in Q2 2026, closing a stake of 149 shares — an estimated $207 sold.

Northwestern Mutual Wealth Management first reported a position in AKBA in Q4 2022 and held it in 4 quarters. The position peaked at $2.04K in Q3 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Akebia Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 149 Akebia Therapeutics shares in Q2 2026, an estimated $207.
  • Northwestern Mutual Wealth Management first reported a position in Akebia Therapeutics in Q4 2022 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Akebia Therapeutics position peaked at $2.04K in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.